Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors

MLA

Stephanie Marion, et al. “Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients with Relapsed Testicular Germ Cell Tumors.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 23, no. 27, Sept. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....707aa32ec7e0811e3b3389fdebb56d75&authtype=sso&custid=ns315887.

APA

Stephanie Marion, G. Varuni Kondagunta, Jennifer Bacik, George J. Bosl, Joel Sheinfeld, Dean F. Bajorin, Robert J. Motzer, & Alessia Donadio. (2005). Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 23(27).

Chicago

Stephanie Marion, G. Varuni Kondagunta, Jennifer Bacik, George J. Bosl, Joel Sheinfeld, Dean F. Bajorin, Robert J. Motzer, and Alessia Donadio. 2005. “Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients with Relapsed Testicular Germ Cell Tumors.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 23 (27). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....707aa32ec7e0811e3b3389fdebb56d75&authtype=sso&custid=ns315887.